or
forgot password

Protocol for Radiofrequency Ablation of Pulmonary Neoplasms


N/A
19 Years
N/A
Not Enrolling
Both
Pulmonary Neoplasms

Thank you

Trial Information

Protocol for Radiofrequency Ablation of Pulmonary Neoplasms


Inclusion Criteria:

The patients enrolled in this study should be judged to have
sufficient survival to benefit from control of local disease and include at least one of
the following:

1. unresectable primary or metastatic lung tumors

2. may benefit from multiple modalities of therapy

3. chemotherapeutic or radiation oncologic options have been exhausted

Exclusion Criteria:

1. co-existing morbidities that preclude the use of surgery

Type of Study:

Interventional

Study Design:

Allocation: Non-Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Principal Investigator

Marshall T. Schreeder, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Comprehensive Cancer Institute

Authority:

United States: Institutional Review Board

Study ID:

CCI LUN 02

NCT ID:

NCT00232128

Start Date:

June 2003

Completion Date:

Related Keywords:

  • Pulmonary Neoplasms
  • Neoplasms
  • Lung Neoplasms

Name

Location
Comprehensive Cancer Institute Huntsville, Alabama  35801